Form 4: IonQ Director Sells Shares Under 10b5-1 Plan

IonQ Director Kathryn K. Chou executed a pre-planned sale of 20,000 common shares following the exercise of stock options.

Summary

• IonQ Director Kathryn K. Chou acquired 20,000 shares of common stock by exercising stock options at a price of $4.61 per share on December 11, 2025.
• Simultaneously, Ms. Chou sold 20,000 shares of common stock at a weighted average price of $51.399 per share on December 11, 2025.
• The sales occurred within a price range of $49.16 to $52.85 per share.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on September 11, 2025.
• Following these transactions, Ms. Chou directly owns 60,839 shares of common stock and 24,900 stock options.
• The exercised options were part of an original grant for 63,900 shares, vesting in three equal annual installments starting July 11, 2023.

Sentiment

Score: 6

Explanation: The transaction represents a profitable exercise and sale for the insider, which is positive for the individual. However, insider selling, even under a 10b5-1 plan, can sometimes be viewed with slight caution by the market, though the pre-planned nature reduces negative implications. The significant profit margin on the options indicates strong stock performance since the grant date.

Positives

• The director realized a significant profit by exercising options at $4.61 and selling shares at an average of $51.399.
• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a structured approach to liquidity rather than opportunistic selling.

Negatives

• A director selling shares could be perceived negatively by some investors, potentially signaling a lack of confidence, although the 10b5-1 plan mitigates this concern.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Kathryn K. Chou, a director of IonQ, Inc., engaged in transactions involving the company's common stock and stock options.

Stakeholder Impact

• Shareholders may observe a director's sale of shares, which could lead to questions about management's long-term outlook, although the 10b5-1 plan mitigates concerns about opportunistic selling.

Key Dates

Recommendation

While the director's sale of shares might raise minor questions, the execution under a Rule 10b5-1 plan suggests a pre-determined liquidity event rather than a reaction to new negative information. The significant profit realized by the director from the option exercise indicates strong past performance of the stock. Without additional company-specific financial or strategic updates, this Form 4 alone does not provide sufficient new information to warrant a change from a 'hold' position, assuming the stock's fundamentals remain consistent with prior assessments.

Keywords

IonQ, IONQ, Kathryn K. Chou, Insider Trading, Form 4, Stock Options, Share Sale, Rule 10b5-1, Quantum Computing